cystografin and Ari sodium iodide i123 100 750 mbq Interactions

Interactions between cystografin(diatrizoate) and Ari sodium iodide i123 100 750 mbq (sodium iodide I-123)

diatrizoate and sodium iodide I-123 (Moderate Drug-Drug)

ADJUST DOSING INTERVAL: Iodine-containing products may affect the pharmacokinetics, pharmacodynamics, and/or diagnostic results of radioiodides.

MANAGEMENT: Iodine preparations including expectorants, vitamins, topicals, and intravascular iodine-containing contrast media should be withheld for 2 to 4 weeks, and cholecystographic agents should be withheld for more than 4 weeks, prior to administration of sodium iodide I-131 or I-123.